This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jim Cramer Answers Twitter (TWTR) Questions on Tesla (TSLA), Tekmira (TKMR), Alcoa (AA) and SolarCity (SCTY)

NEW YORK (TheStreet) -- TheStreet's Jim Cramer answers Twitter (TWTR - Get Report) questions from the floor of the New York Stock Exchange, and this week's first question deals with Tesla (TSLA - Get Report), which received an upgrade from Deutsche (DB - Get Report) on Monday.

Cramer says investors must stay long on Tesla. If Deutsche is right, which Cramer thinks they are, then the scale and profit here are much bigger than he thought. Cramer believes Deutsche's upgrade to "buy" with a $310 price target will move the stock substantially, so he would not sell it.

The next question asks for Cramer's pharma plays given the ongoing Ebola issue, and he notes investors have driven up Tekmira Pharmaceuticals (TKMR), a smaller company. He thinks people keep shorting it and expecting it to go down, but says the stock will obviously soar if the company has an Ebola cure. Cramer thinks the trade has been done and would take profits on the stock.

Must Watch: Cramer Answers Twitter Questions About Tesla's Upgrade, SolarCity

EXCLUSIVE OFFER: See inside Jim Cramer’s multi-million dollar charitable trust portfolio to see the stocks he and Stephanie Link think could be potentially HUGE winners. Click here to see the holdings for FREE.

Another user asks if  Alcoa  (AA - Get Report) is still a good stock for the long term. Cramer notes the stock has doubled in the last year, and stocks usually consolidate after they double. He thinks it could go down before it goes up, but he thinks the company has made a major turn, as has the price of aluminum. Therefore, he tells investors not to sell Alcoa.

Asked about SolarCity's (SCTY - Get Report) recent quarter and its potential for the next quarter, Cramer refers to TheStreet's Herb Greenberg. He wrote the company had a decline in cash flow and did not seem to care about the cash flow at all when the stock was flying, which means investors should be cautious. Cramer agrees with Greenberg and says SolarCity is not for him.

TheStreet Ratings team concurs, as it rates SolarCity a "sell" with a ratings score of D+. TheStreet Ratings Team has this to say about their recommendation:

"We rate SOLARCITY CORP (SCTY) a SELL. This is driven by a few notable weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its poor profit margins, weak operating cash flow, generally high debt management risk and feeble growth in its earnings per share."

You can view the full analysis from the report here: SCTY Ratings Report

EXCLUSIVE OFFER: See inside Jim Cramer’s multi-million dollar charitable trust portfolio to see the stocks he and Stephanie Link think could be potentially HUGE winners. Click here to see the holdings for FREE.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
TKMR $4.02 -1.95%
AA $10.35 -5.57%
DB $17.34 -6.17%
SCTY $26.45 -10.49%
TWTR $14.01 -2.71%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs